Sreesha P. Srinivasa PhD

Dr Srinivasa has more than 20 years of experience in global biopharma majors. He has broad experience in drug discovery and development with special focus on translational sciences. He has led and contributed to several discovery and development programs which have gone onto clinical development including FDA approved drugs Crizotinib and Palbociclib. During a 20+ years career in biopharma, Sreesh has held leadership positions of increasing responsibilities at Gilead, Pfizer, Jubilant, Piramal and Biocon. Prior to joining Oblique, Sreesh was Vice President & Head of Novel Biologics at Biocon Ltd. He holds a PhD in Molecular Biology & Biochemistry from Washington University School of Medicine, St. Louis, USA and an M.Sc. in Molecular Biology and Biotechnology from Indian Agricultural Research Institute, New Delhi, India.